Intercept Pharmaceuticals
acquired by Alfasigma4 known investors
Intercept Pharmaceuticals develops and commercializes treatments for rare and serious liver and other diseases, with a focus on conditions such as primary biliary cholangitis. The page displays corporate news related to Alfasigma, its parent/affiliated pharmaceutical company.
Investors · 4
Founder mafia
4 people who came through Intercept Pharmaceuticals went on to found or lead other companies.
In the news
Frequently asked questions
- What does Intercept Pharmaceuticals do?
- Intercept Pharmaceuticals develops and commercializes treatments for rare and serious liver and other diseases, with a focus on conditions such as primary biliary cholangitis. The page displays corporate news related to Alfasigma, its parent/affiliated pharmaceutical company.
- Who are Intercept Pharmaceuticals's investors?
- Intercept Pharmaceuticals's investors include Aisling Capital, BioBrit, Ridgeback Capital, Samsara BioCapital.
- Who acquired Intercept Pharmaceuticals?
- Intercept Pharmaceuticals was acquired by Alfasigma.